Interviews
This gives it an edge over traditional Western pharmaceutical giants.
1
AI shortens drug discovery to around 1 year in China, Insilico CEO says
2
China to tax offshore trusts as Beijing targets overseas wealth
3
Chinese robot maker AgiBot starts HK IPO process: report
4
Hong Kong eases listing thresholds to draw more IPOs
5
SEA Digest: B Capital names chief AI officer; Finnomena files for Thailand IPO
More Stories
Allianz to acquire HSBC’s Singapore insurance business in $2b deal
Singapore’s Monk’s Hill undergoes restructuring, strategy shift
NIIF invests $15m in specialty healthcare chain NU Hospitals
CXMT to list in Shanghai on July 27 after Asia’s biggest IPO this year
ADM Capital raises $48m for climate finance in Indonesia
Policy & Regulations
The rules feature sweeping anti-avoidance provisions.
IPOs & Markets
Reuters earlier reported that AgiBot appointed banks in October.
The steps are part of a wider push by Hong Kong to strengthen its position as a fundraising hub.
Deals
Finnomena will offer up to 30,000,838 shares, or 15% of its issued and paid-up shares after the offering.
India
Last month, HCLTech acquired a 10.5% stake in Sarvam AI for $150m.
Singapore
Besides Singapore’s ST Engineering, Temasek has never really looked at defence.
The move follows the exit of a Rs 950-crore investment in a global agrochemicals platform.
Malaysia
As Malaysia tightens scrutiny, investment may flow to other countries in the region.
Indonesia
The bank said integration with Bibit and Stockbit continued to support customer acquisition.
